Aytu BioScience (AYTU) Tops Q1 EPS by 65c

Aytu BioScience (NASDAQ: AYTU) reported Q1 EPS of $0.65. Revenue for the quarter came in at $18.5 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Energy Vault Holdings (NRGV) files $300M mixed shelf
• Citi Upgrades Grupo Aeroportuario del Pacifico SAB de CV (GAPB:MM) (PAC) to Buy